News | Heart Failure | November 21, 2022

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.

November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association. With risk factors for cardiovascular disease such as obesity and type 2 diabetes on the rise in the US, the field of cardiovascular medicine finds itself in need of a paradigm shift to improve the cardiovascular health of our nation. 

In a concerted effort to move the needle, clinicians specializing in the prevention of cardiovascular disease, along with the American Society for Preventive Cardiology (ASPC), are rapidly growing the subspecialty referred to commonly as "preventive cardiology". 

 "The importance of cardiovascular disease prevention has never been more urgent for the United States and the world." shares President of the ASPC, Dr. Martha Gulati. "Changing our focus from 'sick care' to true 'health care' starts with cardiovascular disease prevention, and this will be led by preventive cardiologists. This important statement from ASPC should serve as a guide to our cardiology community towards an approach to improve the heart health of our patients." 

Recently published in the American Journal of Preventive Cardiology, this clinical practice statement endorsed by the ASPC delineates the key attributes that define the field of preventive cardiology. Lead author, Charles German, MD shares the importance of this publication: "Despite concerted efforts, high rates of cardiovascular diseases continue to plague our society. Preventive cardiologists are needed now more than ever to help improve the cardiovascular health of our population, and we hope this statement helps bring clarity and unity to the field." 

For more information: https://www.sciencedirect.com/science/article/pii/S2666667722001167  


Related Content

News | Heart Failure

November 30, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 30, 2023
Home
News | Heart Failure

November 30, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home November 30, 2023
Home
News | Heart Failure

November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells ...

Home November 16, 2023
Home
News | Heart Failure

November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a person ...

Home November 16, 2023
Home
News | Heart Failure

November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher ...

Home November 14, 2023
Home
News | Heart Failure

November 13, 2023 — Ultromics, a leading health technology company at the forefront of detection of heart failure and ...

Home November 13, 2023
Home
News | Heart Failure

November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full ...

Home November 03, 2023
Home
News | Heart Failure

October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium ...

Home October 20, 2023
Home
News | Heart Failure

October 18, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home October 18, 2023
Home
Subscribe Now